PERINDOPRIL/AMLODIPINE HCS 4 mg/5 mg, tablet 30 tablets
Active ingredients: Amlodipine, Amlodipine besylate, Perindopril, Perindopril erbumine
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PERINDOPRIL/AMLODIPINE HCS 4 mg/5 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) prédécoupées unitaires OPA : polyamide orienté aluminium PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- HCS (BELGIQUE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Aug 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68351486CIP73014266CIP133400930142660Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PÉRINDOPRIL TERT-BUTYLAMINEcomprimé | 4 mg · un comprimé | SA |
| AMLODIPINEcomprimé | 5 mg · un comprimé | FT |
| PÉRINDOPRILcomprimé | 3,34 mg · un comprimé | FT |
| BÉSILATE D'AMLODIPINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.